|
DBV Technologies S.A (DBVT) DCF تقييم
FR | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
DBV Technologies S.A. (DBVT) Bundle
قم بتقييم التوقعات المالية لشركة DBV Technologies S.A مثل الخبير! توفر لك حاسبة DCF (DBVT) هذه بيانات مالية مملوءة مسبقًا ومرونة كاملة لتعديل نمو الإيرادات و WACC والهوامش والافتراضات الحاسمة الأخرى لتتماشى مع توقعاتك.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | 5.7 | 4.8 | 15.7 | 19.0 | 23.0 | 27.9 | 33.7 | 40.8 |
| Revenue Growth, % | 0 | 0 | 0 | -15.91 | 227.67 | 21.02 | 21.02 | 21.02 | 21.02 | 21.02 |
| EBITDA | -181.4 | -162.7 | -79.8 | -76.7 | -87.5 | -3.8 | -4.6 | -5.6 | -6.7 | -8.2 |
| EBITDA, % | 100 | 100 | -1397.52 | -1597.49 | -556.11 | -20 | -20 | -20 | -20 | -20 |
| Depreciation | 3.1 | 18.8 | 9.3 | 20.3 | -4.6 | 14.1 | 17.1 | 20.7 | 25.0 | 30.3 |
| Depreciation, % | 100 | 100 | 162.46 | 422.9 | -29.09 | 74.18 | 74.18 | 74.18 | 74.18 | 74.18 |
| EBIT | -184.5 | -181.6 | -89.0 | -97.0 | -82.9 | -3.8 | -4.6 | -5.6 | -6.7 | -8.2 |
| EBIT, % | 100 | 100 | -1559.98 | -2020.39 | -527.02 | -20 | -20 | -20 | -20 | -20 |
| Total Cash | 218.6 | 240.8 | 77.3 | 209.2 | 141.4 | 19.0 | 23.0 | 27.9 | 33.7 | 40.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 6.1 | 9.6 | 29.1 | 10.5 | 15.4 | 19.0 | 23.0 | 27.8 | 33.6 | 40.7 |
| Account Receivables, % | 100 | 100 | 509.4 | 218.63 | 98.2 | 99.64 | 99.64 | 99.64 | 99.64 | 99.64 |
| Inventories | 2.6 | 3.9 | -32.9 | -11.2 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | -577.01 | -233.33 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | 27.2 | 24.9 | 11.4 | 14.5 | 23.3 | 19.0 | 23.0 | 27.9 | 33.7 | 40.8 |
| Accounts Payable, % | 100 | 100 | 200.23 | 301.52 | 148.16 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -6.4 | -3.4 | -.9 | -.8 | -.7 | -1.4 | -1.7 | -2.0 | -2.4 | -2.9 |
| Capital Expenditure, % | 100 | 100 | -16.08 | -15.71 | -4.3 | -7.22 | -7.22 | -7.22 | -7.22 | -7.22 |
| Tax Rate, % | -0.00962609 | -0.00962609 | -0.00962609 | -0.00962609 | -0.00962609 | -0.00962609 | -0.00962609 | -0.00962609 | -0.00962609 | -0.00962609 |
| EBITAT | -185.1 | -181.6 | -88.7 | -97.1 | -82.9 | -3.8 | -4.6 | -5.6 | -6.7 | -8.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -169.9 | -173.2 | -76.5 | -77.6 | -95.5 | 1.2 | 10.8 | 13.1 | 15.9 | 19.2 |
| WACC, % | 8.05 | 8.05 | 8.05 | 8.05 | 8.05 | 8.05 | 8.05 | 8.05 | 8.05 | 8.05 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 45.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 20 | |||||||||
| Terminal Value | 324 | |||||||||
| Present Terminal Value | 220 | |||||||||
| Enterprise Value | 265 | |||||||||
| Net Debt | -135 | |||||||||
| Equity Value | 400 | |||||||||
| Diluted Shares Outstanding, MM | 95 | |||||||||
| Equity Value Per Share | 4.21 |
What You Will Receive
- Customizable Excel Template: An editable Excel-based DCF Calculator featuring pre-filled financial data for DBV Technologies S.A. (DBVT).
- Real-Time Data: Access to historical performance metrics and forward-looking projections (highlighted in the yellow cells).
- Assumption Flexibility: Modify key forecast parameters such as revenue growth, EBITDA %, and WACC.
- Instant Calculations: Quickly observe how your inputs affect the valuation of DBV Technologies S.A. (DBVT).
- Professional Resource: Designed for use by investors, CFOs, consultants, and financial analysts.
- User-Friendly Layout: Organized for straightforward navigation and ease of use, complete with step-by-step guidance.
Key Features
- 🔍 Real-Life DBVT Financials: Pre-filled historical and projected data for DBV Technologies S.A.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate DBV’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize DBV’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the prebuilt Excel template featuring DBV Technologies S.A. (DBVT) data.
- Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see recalibrated results, including DBV Technologies S.A. (DBVT)'s intrinsic value.
- Step 5: Make well-informed investment decisions or create reports based on the outputs.
Why Choose This Calculator for DBV Technologies S.A. (DBVT)?
- Designed for Experts: A sophisticated tool tailored for analysts, CFOs, and consultants in the biotech sector.
- Accurate Data: DBV Technologies’ historical and projected financials preloaded for precise analysis.
- Flexible Scenario Analysis: Easily simulate various forecasts and assumptions for informed decision-making.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Step-by-step guidance ensures a smooth and intuitive experience.
Who Should Use This Product?
- Investors: Accurately assess DBV Technologies S.A.’s (DBVT) fair value prior to making investment choices.
- CFOs: Utilize a professional-grade DCF model for comprehensive financial reporting and analysis related to DBVT.
- Consultants: Efficiently modify the template for valuation reports tailored to clients interested in DBVT.
- Entrepreneurs: Acquire knowledge about financial modeling practices employed by leading biotech firms like DBVT.
- Educators: Implement it as a pedagogical resource to illustrate valuation techniques in the biotech sector.
What the Template Contains
- Pre-Filled DCF Model: DBV Technologies S.A.’s (DBVT) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate DBV Technologies S.A.’s (DBVT) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.